Supercharging your practice with machine learning

Quantib to name Arthur Post Uiterweer CEO

Rotterdam, 23 January 2018 – Arthur Post Uiterweer, current Chief Commercial Officer of Quantib, has been named CEO of Quantib effective February 1, 2018. Rudolf Scholte, Founder and CEO, will remain on the Board of Directors to facilitate handover and support the new leadership starting the next chapter.

Learn more

QUANTIB™ ND

Your indispensable tool for atrophy quantification

Quantib™ Neurodegenerative provides quantification and segmentation of MRI brain scans. It allows you to create and display self-defined views including an overlay of segmented brain tissues and CSF. You can easily download and share a comprehensive report including quantified results of several tissues and CSF.

ABOUT US

We push advanced technology forward to make sure radiologists can spend their time in the best way possible. Our engineers go to great lengths to create user-friendly solutions for challenging image analyses issues.

Curious for more detailed information on Quantib™ ND?

We are happy to schedule a call and give you the full tour of all that Quantib™ ND offers during a video conference.

WHITEPAPER

QuantibTM Brain

QuantibTM Brain provides white matter hyperintensity and brain tissue quantification. It offers a tool to objectively assess brain changes in longitudinal exams in neurodegenerative disease.

Download Whitepaper

SAMPLE REPORT
Sample Report

QuantibTM Brain Report

QuantibTM Brain allows you to download the examination results in a comprehensive report including self-selected cross-sections and personal comments.

Download Report

LATEST POSTS

Diagnosing Oligodendrogliomas: Can MRI Scans be as Reliable as a Genomic Profile?

Nov 6, 2017 10:34:10 AM BY Ory Six

Detecting dementia: providing radiologists with more information in less time

Oct 26, 2017 9:18:00 AM BY Ory Six

Subscribe for Updates